MICHELLE LEE: Open Payments
NPI 1922603125 · WILTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 10 payments from 9 companies in 2025. Trend: 2023 $45 · 2024 $341 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $111 |
| Amgen Inc. | 2 | $42 |
| BETA BIONICS, INC. | 1 | $37 |
| ABBVIE INC. | 1 | $31 |
| Mannkind Corporation | 1 | $30 |
| Radius Health, Inc. | 1 | $27 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $18 |
Products named: Omnipod, iLet Bionic Pancreas, XEN GLAUCOMA TREATMENT SYSTEM, AFREZZA, Tymlos, t:slim X2 Insulin Pump with Control-IQ, TZIELD, TEPEZZA.
Industry payments across CT — which companies pay providers there.
